𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Modified presternal esophagogastroplasty in the treatment of esophageal cancer

✍ Scribed by Dr. Vladimir A. Anikin

Publisher
John Wiley and Sons
Year
1992
Tongue
English
Weight
316 KB
Volume
50
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.

✦ Synopsis

Six male patients with locally advanced esophageal cancer underwent surgical treatment including modified presternal esophagogastroplasty. The main reason for this kind of esophagogastroplasty was anticipated risk of transplant gangrene or anastomotic leak. Esophagoplasty technique provides a possibility for prolonged enteral nutrition and facilitates the further reconstruction in case of partial transplant gangrene. There was no hospital mortality. All patients, despite postoperative complications, began their oral food intake with good tolerance of the regular diet.

📜 SIMILAR VOLUMES

Neoadjuvant strategies for the treatment
Neoadjuvant strategies for the treatment of locally advanced esophageal cancer
✍ John R. Hyngstrom; Mitchell C. Posner 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 1 views

## Abstract Patients with locally advanced esophageal carcinoma have consistently poor survival following surgery with associated high systemic and local‐regional failure rates. Neoadjuvant therapeutic strategies have been employed in an attempt to improve outcome with variable success. Randomized

The role of lymphadenectomy in esophagea
The role of lymphadenectomy in esophageal cancer
✍ Gail Darling 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

## Abstract Lymph node metastases are common in esophageal cancer and are associated with a poor prognosis. Resection and examination of 15–18 lymph nodes is required for adequate staging of esophageal cancer. Improved survival is associated with involvement of five or fewer nodes or lymph node rat

Hypermethylation of the GATA gene family
Hypermethylation of the GATA gene family in esophageal cancer
✍ MingZhou Guo; Michael G. House; Yoshimitsu Akiyama; Yu Qi; Domenico Capagna; Joh 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 419 KB 👁 1 views

## Abstract The GATA family of transcription factors promotes the normal development of the gastrointestinal tract during embryogenesis and determines tissue differentiation in adult gut epithelium. Loss of GATA‐4 and GATA‐5 has been reported in human gastric and colon cancer. We examined GATA‐4,‐5

Targeting the epidermal growth factor re
Targeting the epidermal growth factor receptor by erlotinib (Tarceva™) for the treatment of esophageal cancer
✍ Andreas P. Sutter; Michael Höpfner; Alexander Huether; Kerstin Maaser; Hans Sche 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 370 KB 👁 1 views

## Abstract Esophageal cancer is the sixth most common cause of cancer‐related death worldwide. Because of very poor 5‐year survival new therapeutic approaches are mandatory. Erlotinib (Tarceva™), an inhibitor of epidermal growth factor receptor tyrosine kinase (EGFR‐TK), potently suppresses the gr

Does family history of cancer modify the
Does family history of cancer modify the effects of lifestyle risk factors on esophageal cancer? a population-based case–control study in China
✍ Ming Wu; Zuo-Feng Zhang; Ellen Kampman; Jin-Yi Zhou; Ren-Qiang Han; Jie Yang; Xi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 173 KB 👁 2 views

## Abstract A population‐based case–control study on esophageal cancer has been conducted since 2003 in Jiangsu Province, China. The aim of this analysis is to provide further evidence on the relationship between family history of cancer in first‐degree relatives (FH‐FDRs) and the risk of esophagea